Rothschild Investment Corp Cara Therapeutics, Inc. Transaction History

Rothschild Investment Corp

  • $1.19 Billion
  • Q3 2023

A detailed history of Rothschild Investment Corp transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Rothschild Investment Corp holds 10,600 shares of CARA stock, worth $169,176. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,600
Previous 15,100 29.8%
Holding current value
$169,176
Previous $43,000 58.14%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 16, 2023
SELL
$1.67 - $3.33 $7,515 - $14,985
-4,500 Reduced 29.8%
10,600 $18,000
Q2 2023

Jul 18, 2023
SELL
$2.83 - $4.94 $37,639 - $65,702
-13,300 Reduced 46.83%
15,100 $43,000
Q1 2023

Apr 24, 2023
SELL
$4.89 - $12.27 $149,634 - $375,462
-30,600 Reduced 51.86%
28,400 $139,000
Q4 2022

Jan 19, 2023
BUY
$8.88 - $12.77 $9,768 - $14,047
1,100 Added 1.9%
59,000 $634,000
Q3 2022

Oct 21, 2022
BUY
$8.24 - $12.56 $53,560 - $81,640
6,500 Added 12.65%
57,900 $542,000
Q1 2022

Apr 18, 2022
BUY
$9.94 - $12.65 $24,850 - $31,625
2,500 Added 5.11%
51,400 $625,000
Q3 2021

Oct 12, 2021
BUY
$11.55 - $16.06 $132,825 - $184,689
11,500 Added 30.75%
48,900 $756,000
Q2 2021

Jul 19, 2021
SELL
$12.38 - $29.19 $19,808 - $46,704
-1,600 Reduced 4.1%
37,400 $534,000
Q1 2021

Apr 15, 2021
BUY
$15.07 - $21.71 $39,182 - $56,446
2,600 Added 7.14%
39,000 $847,000
Q4 2020

Jan 25, 2021
BUY
$12.72 - $16.16 $45,792 - $58,176
3,600 Added 10.98%
36,400 $551,000
Q3 2020

Oct 22, 2020
BUY
$12.34 - $17.92 $24,680 - $35,840
2,000 Added 6.49%
32,800 $417,000
Q2 2020

Jul 24, 2020
BUY
$12.39 - $17.33 $56,994 - $79,717
4,600 Added 17.56%
30,800 $527,000
Q1 2020

Apr 16, 2020
SELL
$9.12 - $17.78 $3,647 - $7,112
-400 Reduced 1.5%
26,200 $346,000
Q3 2019

Oct 11, 2019
SELL
$18.28 - $26.91 $58,496 - $86,112
-3,200 Reduced 10.74%
26,600 $486,000
Q2 2019

Jul 11, 2019
BUY
$17.68 - $21.57 $150,280 - $183,345
8,500 Added 39.91%
29,800 $641,000
Q1 2019

Apr 18, 2019
SELL
$14.41 - $19.64 $7,205 - $9,820
-500 Reduced 2.29%
21,300 $418,000
Q4 2018

Jan 28, 2019
SELL
$12.45 - $23.47 $13,695 - $25,817
-1,100 Reduced 4.8%
21,800 $283,000
Q3 2018

Oct 17, 2018
BUY
$17.57 - $23.95 $5,271 - $7,185
300 Added 1.33%
22,900 $548,000
Q2 2018

Jul 24, 2018
BUY
$11.6 - $19.27 $3,480 - $5,781
300 Added 1.35%
22,600 $433,000
Q1 2018

Apr 27, 2018
BUY
$11.77 - $16.08 $94,160 - $128,639
8,000 Added 55.94%
22,300 $276,000
Q4 2017

Jan 23, 2018
BUY
$11.86 - $14.08 $169,598 - $201,344
14,300
14,300 $175,000

Others Institutions Holding CARA

# of Institutions
8
Shares Held
797K
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $857M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Rothschild Investment Corp Portfolio

Follow Rothschild Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment Corp , based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email